This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bhardwaj, A. Articles by Traystman, R. J. Search for Related Content PubMed PubMed Citation Articles by Bhardwaj, A. Articles by Traystman, R. J.

(Stroke. 1995;26:1627-1633.)
© 1995 American Heart Association, Inc.

Articles

Adenosine Modulates N-Methyl-D-Aspartate–Stimulated Hippocampal Nitric Oxide Production In Vivo

Anish Bhardwaj, MD; Frances J. Northington, MD; Raymond C. Koehler, PhD; Theodore Stiefel; Daniel F. Hanley, MD Richard J. Traystman, PhD

From the Departments of Neurology (A.B., T.S., D.F.H.), Anesthesiology/Critical Care Medicine (A.B., R.C.K., D.F.H., R.J.T.), and Pediatrics (F.J.N.), The Johns Hopkins Medical Institutions, Baltimore, Md.

Correspondence to Anish Bhardwaj, MD, Neurocritical Care Division, The Johns Hopkins Hospital, Meyer 8-140, 600 N Wolfe St, Baltimore, MD 21287-7840.

Background and Purpose Adenosine acts presynaptically to inhibit release of excitatory amino acids (EAAs) and is thus considered to be neuroprotective. Because EAA-stimulated synthesis of nitric oxide (NO) may play an important role in long-term potentiation and excitotoxic-mediated injury, we tested the hypotheses that adenosine agonists attenuate basal and EAA-induced NO production in the hippocampus in vivo and that adenosine A₁ receptors mediate this response.

Methods Microdialysis probes were placed bilaterally into the CA3 region of the hippocampus of adult Sprague-Dawley rats under pentobarbital anesthesia. Probes were perfused for 5 hours with artificial cerebrospinal fluid containing 3 µmol/L [¹⁴C]L-arginine. Recovery of [¹⁴C]L-citrulline in the effluent was used as a marker of NO production. In 10 groups of rats, time-dependent increases in [¹⁴C]L-citrulline recovery were compared between right- and left-sided probes perfused with various combinations of N-methyl-D-aspartate (NMDA), adenosine agonists, adenosine antagonists, and the NO synthase inhibitor N-nitro-L-arginine methyl ester (L-NAME).

Results Recovery of [¹⁴C]L-citrulline during perfusion with artificial cerebrospinal fluid progressively increased to 141±27 fmol/min (±SEM) over 5 hours. Contralateral perfusion with 1 mmol/L NMDA augmented [¹⁴C]L-citrulline recovery to 317±62 fmol/min. Perfusion of 1 mmol/L L-NAME with NMDA inhibited [¹⁴C]L-citrulline recovery compared with NMDA alone. Perfusion with 0.1 mmol/L 2-chloroadenosine attenuated basal as well as NMDA-enhanced [¹⁴C]L-citrulline recovery. This action of 2-chloroadenosine was reversed by infusion of 0.1 mmol/L 8-cyclopentyl-1,3-dipropylxanthine, a specific A₁ receptor antagonist. Infusion of 0.1 mmol/L (2S)-N⁶-[2-endo-norboryl]adenosine, a specific A₁ receptor agonist, also attenuated the 0.1 mmol/L and 1 mmol/L NMDA-enhanced [¹⁴C]L-citrulline recovery.

Conclusions Using an indirect method of assessing NO production in vivo, these data are consistent with in vitro results showing that NMDA receptor stimulation enhances NO production. Furthermore, we conclude that stimulation of A₁ receptors can attenuate the basal as well as NMDA-induced production of NO. Because NMDA receptor stimulation amplifies glutamate release, our data are consistent with presynaptic A₁ receptor–mediated inhibition of EAA release and consequent downregulation of NO production.

Key Words: adenosine • hippocampus • N-methyl-D-aspartate • nitric oxide • rats

This article has been cited by other articles:

				T. Goyagi, T. J.K. Toung, J. R. Kirsch, R. J. Traystman, R. C. Koehler, P. D. Hurn, and A. Bhardwaj Neuroprotective {kappa}-Opioid Receptor Agonist BRL 52537 Attenuates Ischemia-Evoked Nitric Oxide Production In Vivo in Rats Stroke, June 1, 2003; 34(6): 1533 - 1538. [Abstract] [Full Text] [PDF]

				T. Goyagi, A. Bhardwaj, R. C. Koehler, R. J. Traystman, P. D. Hurn, and J. R. Kirsch Potent {sigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Provides Ischemic Neuroprotection Without Altering Dopamine Accumulation In Vivo in Rats Anesth. Analg., February 1, 2003; 96(2): 532 - 538. [Abstract] [Full Text] [PDF]

				T. Goyagi, S. Goto, A. Bhardwaj, V. L. Dawson, P. D. Hurn, and J. R. Kirsch Neuroprotective Effect of {{sigma}}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production Stroke, July 1, 2001; 32(7): 1613 - 1620. [Abstract] [Full Text] [PDF]

				A. Bhardwaj, F. J. Northington, J. R. Carhuapoma, J. R. Falck, D. R. Harder, R. J. Traystman, and R. C. Koehler P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D-aspartate Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1616 - H1624. [Abstract] [Full Text] [PDF]

				T. J. Toung, A. Bhardwaj, V. L. Dawson, T. M. Dawson, R. J. Traystman, P. D. Hurn, and P. H. Chan Neuroprotective FK506 Does Not Alter In Vivo Nitric Oxide Production During Ischemia and Early Reperfusion in Rats • Editorial Comment Stroke, June 1, 1999; 30(6): 1279 - 1285. [Abstract] [Full Text] [PDF]

				K P S J Murphy and T V P Bliss Photolytically released nitric oxide produces a delayed but persistent suppression of LTP in area CA1 of the rat hippocampal slice J. Physiol., March 1, 1999; 515(2): 453 - 462. [Abstract] [Full Text] [PDF]

				A. Bhardwaj, M. Sawada, E. D. London, R. C. Koehler, R. J. Traystman, J. R. Kirsch, and F. M. Faraci Potent {varsigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine Modulates Basal and N-Methyl-D-Aspartate–Evoked Nitric Oxide Production In Vivo • Editorial Comment Stroke, November 1, 1998; 29(11): 2404 - 2411. [Abstract] [Full Text] [PDF]

				H. H. D. Lam, A. Bhardwaj, M. T. O'Connell, D. F. Hanley, R. J. Traystman, and M. V. Sofroniew Nerve growth factor rapidly suppresses basal, NMDA-evoked, and AMPA-evoked nitric oxide synthase activity in rat hippocampus in vivo PNAS, September 1, 1998; 95(18): 10926 - 10931. [Abstract] [Full Text] [PDF]

				T. Tatlisumak, K. Takano, R. A. D. Carano, L. P. Miller, A. C. Foster, M. Fisher, C. Y. Hsu, and W. Lin Delayed Treatment With an Adenosine Kinase Inhibitor, GP683, Attenuates Infarct Size in Rats With Temporary Middle Cerebral Artery Occlusion • Editorial Comment Stroke, September 1, 1998; 29(9): 1952 - 1958. [Abstract] [Full Text] [PDF]

				A. Bhardwaj, F. J. Northington, R. N. Ichord, D. F. Hanley, R. J. Traystman, and R. C. Koehler Characterization of Ionotropic Glutamate Receptor–Mediated Nitric Oxide Production In Vivo in Rats Stroke, April 1, 1997; 28(4): 850 - 857. [Abstract] [Full Text]